Rep. Norm Thurston — Voting Record

Bill

Number

H.B. 435 First Substitute (2019GS)

Sponsor

Rep. Eliason, S.

Final action

Governor Signed 3/26/2019

Outcome

Became law — signed by Gov. Gary R. Herbert

Summary

What it does

• This bill:
• defines terms; and
• requires the state Medicaid program and Public Employees' Benefit and Insurance Program to cover exome sequence testing for certain enrollees.

Every vote on this bill

Bill text

UNDIAGNOSED CHILDREN INSURANCE COVERAGE
AMENDMENTS
GENERAL SESSION
STATE OF UTAH
Chief Sponsor: Steve Eliason
Senate Sponsor: 
David G. Buxton
LONG TITLE
General Description:
This bill requires the state Medicaid program and Public Employees' Benefit and
Insurance Program to cover exome sequence testing.
Highlighted Provisions:
This bill:
▸ defines terms; and
▸ 
requires the state Medicaid program and Public Employees' Benefit and Insurance
Program to cover exome sequence testing for certain enrollees.
Money Appropriated in this Bill:
None
Other Special Clauses:
None
Utah Code Sections Affected:
ENACTS:
26-18-25
, Utah Code Annotated 1953
49-20-419
, Utah Code Annotated 1953
Be it enacted by the Legislature of the state of Utah:
Section 1. Section 
26-18-25
 is enacted to read:
 26-18-25.
Coverage of exome sequence testing.
(1) As used in this section, "exome sequence testing" means a genomic technique for
sequencing the genome of an individual for diagnostic purposes.
(2) The Medicaid program shall reimburse for exome sequence testing:
(a) for an enrollee who:
(i) is younger than 21 years of age; and
(ii) who remains undiagnosed after exhausting all other appropriate diagnostic-related
tests;
(b) performed by a nationally recognized provider with significant experience in exome
sequence testing;
(c) that is medically necessary; and
(d) at a rate set by the Medicaid program.
Section 2. Section 
49-20-419
 is enacted to read:
 49-20-419.
Coverage of exome sequence testing.
(1) As used in this section, "exome sequence testing" means a genomic technique for
sequencing the genome of an individual for diagnostic purposes.
(2) Beginning July 1, 2019, the program shall provide coverage for exome sequence
testing:
(a) for a covered individual within the state risk pool who:
(i) is younger than 21 years of age; and
(ii) who remains undiagnosed after exhausting all other appropriate diagnostic-related
tests;
(b) performed by a nationally recognized provider with significant experience in exome
sequence testing;
(c) that is medically necessary; and
(d) at a rate set by the program.